Clinical Trial Update: A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating navepegritide in combination with lonapegsomatropin for children with achondroplasia; current status is active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• Navepegritide (Navepegritide)
• lonapegsomatropin (lonapegsomatropin)

Snippet

Sponsor: Ascendis Pharma Growth Disorders A/S | Conditions: Achondroplasia | Phase 2 | Status: ACTIVE_NOT_RECRUITING